Drug Type Small molecule drug |
Synonyms EGRIFTA WR |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (25 Mar 2025), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
HIV Infections | United States | 25 Mar 2025 | |
HIV-Associated Lipodystrophy Syndrome | United States | 25 Mar 2025 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Nonalcoholic Steatohepatitis | Phase 2 | Canada | 23 Mar 2022 |